The 6th Edition of the International Vaccines Congress was successfully held from October 5–7, 2026, in Tokyo, Japan. The congress brought together researchers, scientists, healthcare professionals, industry experts, and academicians to share knowledge, exchange ideas, and discuss the latest advancements in vaccine research, development, immunization, and public health. The event provided a valuable platform for scientific discussions, knowledge sharing, and professional networking, fostering collaboration and highlighting emerging innovations in vaccine science and technology.
The congress concluded successfully, marking another significant milestone in advancing vaccine research and strengthening global efforts toward improved healthcare and disease prevention. We sincerely thank all the speakers, delegates, participants, and supporting partners for their valuable contributions to the success of the 6th Edition of the International Vaccines Congress.
Latest highlights & testimonials
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan